# US 2015/0104384 A1 · Amido-benzyl sulfone and sulfoxide derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104384 A1
- Document ID: US20150104384A1
- Status: Published application
- Kind: A1
- Application number: 14/382,141
- Filed: 2013-03-01
- Published: 2015-04-16
- Earliest claimed: 2012-03-02
- Inventors: Kenneth W. Bair; Timm R. Baumeister; Alexandre J. Buckmelter; Karl H. Clodfelter; Peter Dragovich; Francis Gosselin; Janet Gunzner-Toste; Bingsong Han; Jian Lin; Xiongcai Liu; Dominic J. Reynolds; Chase C. Smith; Zhongguo Wang; Mark Zak; Yamin Zhang; Guiling Zao; Xiaozhang Zheng; Po-Wai Yuen
- Web page: https://patentgrep.com/patent/US20150104384A1

## CPC

- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- A61K 31/454: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A61K 31/4545: containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A61K 31/46: 8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A61K 31/496: Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A61K 31/5025: ortho- or peri-condensed with heterocyclic ring systems
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 31/5386: spiro-condensed or forming part of bridged ring systems
- A61K 31/551: having two nitrogen atoms, e.g. dilazep
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/04: Antibacterial agents
- A61P 35/00: Antineoplastic agents
- A61P 35/02: specific for leukemia
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 471/04: Ortho-condensed systems
- C07D 487/04: Ortho-condensed systems
- C07D 491/048: the oxygen-containing ring being five-membered
- C07D 495/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to certain amido-benzyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

## Claims

### Claim 1

A compound of Formula (I):
wherein:
E is O or is absent;
R is (a) an 8-, 9-, or 10-membered bicyclic heteroaryl comprising one heteroatom selected from N, S, and O, and one, two, or three additional N atoms, wherein said bicyclic heteroaryl is unsubstituted or is substituted with one or more substituents selected from the group consisting of deuterium, amino, alkylamino, dialkylamino, alkyl, halo, cyano, haloalkyl, hydroxy, hydroxyalkyl, and alkoxy, and wherein one or more N atoms of said bicyclic heteroaryl is optionally an N-oxide; or
(b) a five- or six-membered nitrogen-linked heterocycloalkyl ring fused to a phenyl or monocyclic six-membered heteroaryl, wherein said phenyl or heteroaryl is unsubstituted or is substituted with one or more substituents selected from the group consisting of deuterium, amino, alkylamino, dialkylamino, alkyl, halo, cyano, haloalkyl, hydroxy, hydroxyalkyl, and alkoxy;
R1 is (I) a saturated, monocyclic heterocycloalkyl, which is unsubstituted or substituted with one or more substituents RX;
wherein each RX substituent is independently selected from the group consisting of: deuterium, halo, hydroxy, cyano, —NRaRb, -alkylenyl-NRaRb, oxo, alkyl, hydroxyalkyl, cyanoalkyl, haloalkyl, alkoxy, haloalkoxy, alkoxyalkyl-, —S-alkyl, alkenyl, alkynyl, aryl, arylalkyl-, aryloxy-, arylalkoxy-, cycloalkyl, cycloalkoxy, (cycloalkyl)alkyl-, heterocycloalkyl, (heterocycloalkyl)alkyl-, (heterocycloalkyl)alkoxy-, —C(O)alkyl, —CO2alkyl, —CO2H, —C(O)cycloalkyl, —C(O)aryl, —C(O)heterocycloalkyl, —S(O)-alkyl, —SO2-alkyl, —SO2-aryl, —SO2-(haloalkyl), —CONH2, C(O)NH(alkyl), —C(O)NH(haloalkyl), —C(O)N(alkyl)2, —C(O)NH(cycloalkyl), heteroaryl, (heteroaryl)alkyl-, —N(Rc)—C(O)-alkyl, —N(Rc)—C(O)-aryl, —N(Rc)—CO2-alkyl, —SO2NH2, —SO2NH(alkyl), —SO2N(alkyl)2, —SO2NH(cycloalkyl), and —N(H)(SO2alkyl), or two adjacent RX substituents taken together form a phenyl ring,
wherein each of said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, and phenyl substituents within RX is independently unsubstituted or substituted with one or more substituents selected from the group consisting of alkyl, halo, hydroxy, cyano, alkoxy, amino, —NHCO2alkyl, —C(O)alkyl, and —CO2alkyl;
wherein Ra and Rb are each independently H, alkyl, alkoxy, alkoxyalkyl, cyanoalkyl, or haloalkyl; and
Rc is H or alkyl; or
(2) a saturated, bicyclic or tricyclic, nitrogen-linked heterocycloalkyl, wherein said heterocycloalkyl comprises a fused, bridged, or spiro bicyclic system, and said heterocycloalkyl is unsubstituted or substituted with one or more substituents independently selected from the group consisting of: alkyl, halo, haloalkyl, hydroxy, hydroxyalkyl, alkoxy, cyano, cyanoalkyl, oxo, —NRdRe, -alkylenyl-NRdRe, —C(O)alkyl, —CO2alkyl, and —SO2alkyl;
wherein Rd is H or alkyl; and
Rc is H, alkyl, haloalkyl, —C(O)alkyl, —CO2alkyl, or —SO2alkyl; and
R2 and R3 are each independently H or deuterium;
or a pharmaceutically acceptable salt thereof,
with the proviso that the compound of Formula I is not one of the following compounds:

### Claim 2 (depends on 1)

The compound of claim 1, wherein E is O.

### Claim 3 (depends on 1)

The compound of claim 1, wherein E is absent.

### Claim 4 (depends on 1)

The compound of claim 1, wherein R is an unsubstituted or substituted bicyclic heteroaryl.

### Claim 5 (depends on 1)

The compound of claim 1, wherein R is an unsubstituted or substituted 8- or 9-membered heteroaryl.

### Claim 6 (depends on 1)

The compound of claim 1, wherein R is a bicyclic heteroaryl selected from the group consisting of:
each unsubstituted or substituted as in claim 1.

### Claim 7 (depends on 1)

The compound of claim 1, wherein R is a five- or six-membered nitrogen-linked heterocycloalkyl ring fused to an unsubstituted or substituted phenyl or monocyclic heteroaryl.

### Claim 8 (depends on 1)

The compound of claim 1, wherein R is

### Claim 9 (depends on 1)

The compound of claim 1, wherein R1 is a saturated, monocyclic, nitrogen-linked heterocycloalkyl, unsubstituted or substituted as in claim 1.

### Claim 10 (depends on 9)

The compound of claim 9, wherein the saturated, monocyclic, nitrogen-linked heterocycloalkyl is azetidinyl, pyrrolidinyl, piperidinyl, morpholinyl, piperazinyl, azepanyl, or diazepanyl, unsubstituted or substituted as in claim 9.

### Claim 11 (depends on 9)

The compound of claim 9, wherein the saturated, monocyclic, nitrogen-linked heterocycloalkyl is substituted with one or more RX groups independently selected from the group consisting of hydroxy, methoxy, cyano, cyanomethyl, amino, difluoroethylamino, methoxyethylamino, cyanoethylamino, hydroxymethyl, pyrrolidinyl, methyl, ethyl, isopropyl, isobutyl, trifluoroethyl, trifluoromethyl, cyclohexyl, tetrahydropyranyl, pyrrolidinyl, oxetanyl, fluoro, —C(O)(4-methyl-piperazin-1-yl), 4-methylpiperazinyl, —NH(Boc), acetyl, hydroxyethyl, dimethylaminoethyl, cyanoethyl, methoxyethyl, —N(Me)acetyl), dimethylamino, —C(O)(dimethylamino), and oxo, and where two adjacent substituents taken together form a phenyl ring.

### Claim 12 (depends on 9)

The compound of claim 9, wherein the saturated, monocyclic, nitrogen-linked heterocycloalkyl is substituted with 1, 2, or 3 RX groups independently selected from the group consisting of: methyl, ethyl, isopropyl, hydroxy, methoxy, amino, cyano, fluoro, and trifluoromethyl.

### Claim 13 (depends on 1)

The compound of claim 1, wherein R1 is a saturated, monocyclic, carbon-linked heterocycloalkyl, unsubstituted or substituted as in claim 1.

### Claim 14 (depends on 13)

The compound of claim 13, wherein the saturated, monocyclic, carbon-linked heterocycloalkyl is tetrahydropyranyl, pyrrolidinyl, piperidinyl, or tetrahydrofuranyl, unsubstituted or substituted as described in claim 13.

### Claim 15 (depends on 13)

The compound of claim 13, wherein the saturated, monocyclic, carbon-linked heterocycloalkyl is pyrrolidin-3-yl, tetrahydropyran-4-yl, tetrahydropyran-3-yl, piperidin-3-yl, piperidin-4-yl, or tetrahydrofuran-3-yl, unsubstituted or substituted as described in claim 13.

### Claim 16 (depends on 13)

The compound of claim 13, wherein the saturated, monocyclic, carbon-linked heterocycloalkyl is substituted with one or more substituents independently selected from the group consisting of methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, trifluoromethyl, trifluoroethyl, acetyl, propionyl, butyryl, isobutyryl, benzoyl, methylsulfonyl, phenylsulfonyl, tert-butoxycarbonyl, tetrahydropyranyl, and oxetanyl.

### Claim 17 (depends on 1)

The compound of claim 1, wherein R1 is a saturated, bicyclic or tricyclic, nitrogen-linked heterocycloalkyl, wherein said heterocycloalkyl comprises a fused, bridged, or spiro bicyclic system, and is unsubstituted or substituted as described in claim 1.

### Claim 18 (depends on 17)

The compound of claim 17, wherein R1 is a bridged, bicyclic, nitrogen-linked heterocycloalkyl, unsubstituted or substituted as described for claim 17.

### Claim 19 (depends on 17)

The compound of claim 17, wherein R1 is an azetidine, pyrrolidine, piperidine, morpholine, azepane, 1,4-diazepane, or azocane ring, substituted with two substituents on the same or different carbons that together form a C1-6alklenyl group, wherein one carbon atom of the alkylenyl group is optionally replaced with one or two O, S, or NH groups, and the resulting bicyclic heterocycloalkyl is optionally further substituted as described for claim 17.

### Claim 20 (depends on 17)

The compound of claim 17, wherein R1 is substituted with one or more substituents independently selected from the group consisting of: methyl, ethyl, isopropyl, acetyl, fluoro, oxo, hydroxy, tert-butoxycarbonyl, amino, aminomethyl, tert-butoxycarbonylamino, and tert-butoxycarbonyl-aminomethyl.

### Claim 21 (depends on 1)

The compound of claim 1, wherein both R2 and R3 are H.

### Claim 22

A compound selected from the group consisting of:
5H-Imidazo[1,2-b]pyrazole-2- carboxylic acid 4-(piperidine-1- sulfonyl)-benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-(8-oxa-3-aza- bicyclo[3.2.1]octane-3-sulfonyl)- benzylamide;
Thieno[2,3-c]pyridine-2-carboxylic acid 4-(8-oxa-3-aza- bicyclo[3.2.1]octane-3-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(8-oxa-3-aza- bicyclo[3.2.1]octane-3-sulfonyl)- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(piperidine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(piperidine-1- sulfonyl)-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(4-methoxy-piperidine-1- sulfonyl)-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(morpholine-4-sulfonyl)- benzylamide;
1H-Pyrazolo[2,3-b]pyridine-5- carboxylic acid 4-(morpholine-4- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(morpholine-4- sulfonyl)-benzylamide;
Thieno[2,3-c]pyridine-2-carboxylic acid 4-(morpholine-4-sulfonyl)- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(4-cyano-piperidine-1- sulfonyl)-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(4-cyanomethyl-piperidine- 1-sulfonyl)-benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-(morpholine-4- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(morpholine-4- sulfonyl)-benzylamide;
Imidazo[1,2-b]pyridazine-6- carboxylic acid 4-(piperidine-1- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-methyl- piperazine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-isopropyl- piperazine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(3-hydroxy- piperidine-1-sulfonyl)-benzylamide (racemic);
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(tetrahydro- pyran-4-sulfonyl)-benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(tetrahydro- pyran-4-sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(tetrahydro- pyran-4-sulfonyl)-benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-(tetrahydro- pyran-4-sulfonyl)-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(tetrahydro-pyran-4- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[4-(2,2,2- trifluoro-ethyl)-piperazine-1- sulfonyl]-benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(8-oxa-3-aza- bicyclo[3.2.1]octane-3-sulfonyl)- benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(8-oxa-3-aza- bicyclo[3.2.1]octane-3-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-hydroxy- piperidine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(4-hydroxy- piperidine-1-sulfonyl)- benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(4-hydroxy- piperidine-1-sulfonyl)- benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-(4-hydroxy- piperidine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(3-hydroxy- piperidine-1-sulfonyl)-benzylamide (racemic);
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(3-hydroxy- piperidine-1-sulfonyl)-benzylamide (racemic);
Furo[2,3-c]pyridine-2-carboxylic acid 4-(3-hydroxy-piperidine-1- sulfonyl)-benzylamide (racemic);
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-(3-hydroxy- piperidine-1-sulfonyl)-benzylamide (racemic);
Thieno[2,3-c]pyridine-2-carboxylic acid 4-(4-amino-piperidine-1- sulfonyl)-benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-[4-(2,2-difluoro- ethylamino)-piperidine-1-sulfonyl]- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(4-hydroxy-piperidine-1- sulfonyl)-benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-[4-(2-methoxy- ethylamino)-piperidine-1-sulfonyl]- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-cyclohexyl- piperazine-1-sulfonyl)- benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(piperidine-4- sulfonyl)-benzylamide;
Thieno[2,3-c]pyridine-2-carboxylic acid 4-(piperidine-4-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-isobutyl- piperazine-1-sulfonyl)- benzylamide;
Thieno[2,3-c]pyridine-2-carboxylic acid 4-((1R,3R,5S)-3-amino-8-aza- bicyclo[3.2.1]octane-8-sulfonyl)- benzylamide;
[1,2,4]Triazolo[1,5-a]pyridine-6- carboxylic acid 4-(piperidine-1- sulfonyl)-benzylamide;
Thieno[2,3-c]pyridine-2-carboxylic acid 4-((3R,5S)-3,5-dimethyl- piperazine-1-sulfonyl)- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-[1-(tetrahydro-pyran-4-yl)- piperidine-4-sulfonyl]- benzylamide;
Pyrazolo[1,5-a]pyridine-5- carboxylic acid 4-(piperidine-1- sulfonyl)-benzylamide.
1H-Pyrazolo[4,3-b]pyridine-6- carboxylic acid 4-(piperidine-1- sulfonyl)-benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-((R)-3-hydroxy- piperidine-1-sulfonyl)- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-((S)-3-hydroxy-piperidine-1- sulfonyl)-benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-((S)-3-hydroxy- piperidine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-((R)-3-hydroxy- piperidine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-((S)-3-hydroxy- piperidine-1-sulfonyl)- benzylamide;
[1-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-piperidin-4-yl]- carbamic acid tert-butyl ester;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-[1-(tetrahydro- pyran-4-yl)-piperidine-4-sulfonyl]- benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-[4-(2-cyano- ethylamino)-piperidine-1-sulfonyl]- benzylamide;
Pyrazolo[1,5-a]pyrimidine-5- carboxylic acid 4-(piperidine-1- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[4-(tetrahydro- pyran-4-yl)-piperazine-1-sulfonyl]- benzylamide;
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-((3R,5S)-3,5- dimethyl-piperazine-1-sulfonyl)- benzylamide;
cis-Furo[2,3-c]pyridine-2- carboxylic acid 4-((3R,5S)-3,5- dimethyl-piperazine-1-sulfonyl)- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(1-acetyl-piperidine-4- suflonyl)-benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-[1-(2,2,2- trifluoro-ethyl)-piperidine-4- sulfonyl]-benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-[1-(2,2,2- trifluoro-ethyl)-piperidine-4- suflonyl]-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[1-(2,2,2- trifluoro-ethyl)-piperidine-4- suflonyl]-benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-[1-(2,2,2- trifluoro-ethyl)-piperidine-4- sulfonyl]-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-[1-(2,2,2-trifluoro-ethyl)- piperidine-4-sulfonyl]- benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-[1-(tetrahydro- pyran-4-yl)-piperidine-4-sulfonyl]- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[1-(tetrahydro- pyran-4-yl)-piperidine-4-sulfonyl]- benzylamide;
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-((3aR,6aS)-5,5- difluoro-hexahydro- cyclopenta[c]pyrrole-2-sulfonyl)- benzylamide;
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[(3aR,6aS)- (tetrahydro-furo[3,4-c]pyrrol-5- yl)sulfonyl]-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(hexahydro- furo[2,3-c]pyrrole-5-sulfonyl)- benzylamide (mixture of diastereomers);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4,4-difluoro- hexahydro-cyclopenta[c]pyrrole-2- sulfonyl)-benzylamide (isomer A);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4,4-difluoro- hexahydro-cyclopenta[c]pyrrole-2- sulfonyl)-benzylamide (isomer B);
1H-Pyrrolo[23,2-c]pyridine-2- carboxylic acid 4-[(S)-(tetrahydro- furan-3-yl)sulfonyl]-benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-[(S)-(tetrahydro- furan-3-yl)sulfonyl]-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[(S)-(tetrahydro- furan-3-yl)suflonyl]-benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-[1-(tetrahydro- pyran-4-yl)-piperidine-4-sulfonyl]- benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-[(R)-(tetrahydro- furan-3-yl)sulfonyl]-benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-[(R)-(tetrahydro- furan-3-yl)sulfonyl]-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[(R)-(tetrahydro- furan-3-yl)sulfonyl]-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-((R)-3-hydroxy-piperidine-1- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[(3R,5S)-3,5- dimethyl-4-(2,2,2-trifluoro-ethyl)- piperazine-1-sulfonyl]- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[(1S,4S)-(2-oxa- 5-aza-bicyclo[2.2.1]hept-5- yl)sulfonyl]-benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(1-acetyl- piperidine-4-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(1-acetyl- piperidine-4-sulfonyl)- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-[(S)-(tetrahydro-furan-3- yl)sulfonyl]-benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-[(S)-(tetrahydro- furan-3-yl)sulfonyl]-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-[(R)-(tetrahydro-furan-3- yl)sulfonyl]-benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-[(R)-(tetrahydro- furan-3-yl)sulfonyl]-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(piperidine-4- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-oxetan-3-yl- piperazine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-acetyl- piperazine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[4-(2-hydroxy- ethyl)-piperazine-1-sulfonyl]- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-cyano- piperidine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4- hydroxymethyl-piperidine-1- suflonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-pyrrolidin-1- yl-piperidine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[4-(2-methoxy- ethyl)-piperazine-1-sulfonyl]- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(3,3-difluoro- pyrrolidine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-acetyl- [1,4]diazepane-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[3-(acetyl- methyl-amino)pyrrolidine-1- sulfonyl]-benzylamide (racemic);
7-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-2,7-diaza- spiro[4.5]decane-2-carboxylic acid tert-butyl ester (racemic);
8-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-2,8-diaza- spiro[4.5]decane-2-carboxylic acid tert-butyl ester;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[4-(2-cyano- ethyl)-piperazine-1-sulfonyl]- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[4-(2- dimethylamino-ethyl)-piperazine-1- suflonyl]-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-((R)-2- hydroxymethyl-pyrrolidine-1- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-((S)-2- hydroxymethyl-pyrrolidine-1- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-((S)-3- dimethyalmino-pyrrolidine-1- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[4-(4-methyl- piperazine-1-carbonyl)-piperidine- 1-sulfonyl]-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-[4-(4-methyl- piperazin-1-yl)-piperidine-1- sulfonyl]-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(3- trifluoromethyl-pyrrolidine-1- sulfonyl)-benzylamide (racemic);
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4,4-difluoro- piperidine-1-sulfonyl)- benzylamide;
1H-Pyrrolo[3,2-c]pyrridine-2- carboxylic acid 4-(1-acetyl- piperidine-4-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(1-oxetan-3-yl- piperidine-4-sulfonyl)- benzylamide;
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-(1-oxetan-3-yl- piperidine-4-sulfonyl)- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(1-oxetan-3-yl-piperidine-4- sulfonyl)-benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(4-oxetan-3-yl- piperazine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(1-oxetan-3-yl- piperidine-4-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(4-oxetan-3-yl- piperazine-1-sulfonyl)- benzylamide;
Thieno[2,3-c]pyridine-2-carboxylic acid 4-(1-oxetan-3-yl-piperidine-4- sulfonyl)-benzylamide;
9-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-3,9-diaza- spiro[5.5]undecane-3-carboxylic acid tert-butyl ester;
9-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-2,9-diaza- spiro[5.5]undecane-2-carboxylic acid tert-butyl ester;
8-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-1,8-diaza- spiro[5.5]undecane-1-carboxylic acid tert-butyl ester (racemic);
4-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-1-oxa-5,9-diaza- spiro[5.5]undecane-9-carboxylic acid tert-butyl ester;
8-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-1,8-diaza- spiro[4.5]decane-1-carboxylic acid tert-butyl ester;
4-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-1-oxa-4,8-diaza- spiro[5.5]undecane-8-carboxylic acid tert-butyl ester (racemic);
[7-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-7-aza- spiro[3.5]non-2-yl]-carbamic acid tert-butyl ester;
cis-3-(4-{[(Imidazo[1,2-a]pyridine- 6-carbonyl)-amino]-methyl}- benzenesulfonyl)-3,6-diaza- bicyclo[3.2.0]heptane-6-carboxylic acid tert-butyl ester (racemic);
[2-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-2-aza- bicyclo[2.1.1]hex-1-ylmethyl]- carbamic acid tert-butyl ester;
cis-4-(4-{[(Imidazo[1,2-a]pyridine- 6-carbonyl)-amino]-methyl}- benzenesulfonyl)-hexahydro- pyrrolo[3,4-b][1,4]oxazine-6- carboxylic acid tert-butyl ester (racemic);
2-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-2,9-diaza- spiro[5.5]undecane-9-carboxylic acid tert-butyl ester;
cis-[3-(4-{[(Imidazo[1,2- a]pyridine-6-carbonyl)-amino]- methyl}-benzenesulfonyl)-3-aza- bicyclo[3.1.0]hex-1-yl]-carbamic acid tert-butyl ester (racemic);
cis-7-(4-{[(Imidazo[1,2-a]pyridine- 6-carbonyl)-amino]-methyl}- benzenesulfonyl)-9-oxa-3,7-diaza- bicyclo[3.3.1]nonane-3-carboxylic acid tert-butyl ester (racemic);
cis-4-(4-{[(Imidazo[1,2-a]pyridine- 6-carbonyl)-amino]-methyl}- benzenesulfonyl)-hexahydro- pyrrolo[3,4-b][1,4]oxazine-6- carboxylic acid tert-butyl ester (racemic);
cis-1-(4-{[(Imidazo[1,2-a]pyridine- 6-carbonyl)-amino]-methyl}- benzenesulfonyl)-hexahydro- pyrrolo[3,4-b]pyrrole-5-carboxylic acid tert-butyl ester (racemic);
cis-5-(4-{[(Imidazo[1,2-a]pyridine- 6-carbonyl)-amino]-methyl}- benzenesulfonyl)-hexahydro- pyrrolo[3,4-b]pyrrole-1-carboxylic acid tert-butyl ester (racemic);
cis-5-(4-{[(Imidazo[1,2-a]pyridine- 6-carbonyl)-amino]-methyl}- benzenesulfonyl)-hexahydro- pyrrolo[3,4-c]pyrrole-2-carboxylic acid tert-butyl ester (racemic).
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(9-hydroxy-3- oxa-7-aza-bicyclo[3.3.1]nonane-7- sulfonyl)-benzylamide (mixture of diastereomers);
trans-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(3-hydroxy-4- methyl-pyrrolidine-1-sulfonyl)- benzylamide (racemic);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(7-hydroxy-3- oxa-9-aza-bicyclo[3.3.1]nonane-9- sulfonyl)-benzylamide (racemic);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(5,5-difluoro-2- aza-bicyclo[2.2.1]heptane-2- sulfonyl)-benzylamide (racemic);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(7-methyl-9-oxa- 3,7-diaza-bicyclo[3.3.1]nonane-3- sulfonyl)-benzylamide (racemic);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(5-methyl- hexahydro-pyrrolo[3,4-b]pyrrole-1- sulfonyl)-benzylamide (racemic);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(1-methyl- hexahydro-pyrrolo[3,4-b]pyrrole-5- sulfonyl)-benzylamide (racemic);
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(4-hydroxy-4- methyl-piperidine-1-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(hexahydro- furo[3,2-c]pyridine-5-sulfonyl)- benzylamide (mixture of diastereomers);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(6,6-difluoro-3- aza-bicyclo[3.2.0]heptane-3- sulfonyl)-benzylamide (racemic);
Pyrazolo[1,5-a]pyrazine-2- carboxylic acid 4-(piperidine-1- sulfonyl)-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(4-oxetan-3-yl-piperazine-1- sulfonyl)-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-((S)-3-hydroxy-piperidine-1- sulfonyl)-benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-((R)-3-hydroxy-piperidine-1- sulfonyl)-benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(2,8-diaza- spiro[4.5]decane-8-sulfonyl)- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(tetrahydro-furo[3,4- c]pyrrole-5-sulfonyl)-benzylamide (mixture of diastereomers);
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-(tetrahydro- pyran-3-sulfonyl)-benzylamide (racemic);
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(tetrahydro- pyran-3-sulfonyl)-benzylamide (racemic);
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(4-pyrrolidin-1- yl-piperidine-1-sulfonyl)- benzylamide;
Furo[2,3-c]pyridine-2-carboxylic acid 4-(4-pyrrolidin-1-yl- piperidine-1-sulfonyl)- benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(tetrahydro- furo[3,4-c]pyrrole-5-sulfonyl)- benzylamide (mixture of diastereomers);
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(2-aza- bicyclo[2.1.1]hexane-2-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(3-aza- bicyclo[3.1.0]hexane-3-sulfonyl)- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(3-hydroxy-3- methyl-pyrrolidine-1-sulfonyl)- benzylamide (racemic);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(9-methyl-3-oxa- 7,9-diaza-bicyclo[3.3.1]nonane-7- sulfonyl)-benzylamide (racemic);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(5-acetyl-2,5- diaza-bicyclo[2.2.1]heptane-2- sulfonyl)-benzylamide (racemic)
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(5-fluoro-2-aza- bicyclo[2.2.1]heptane-2-sulfonyl)- benzylamide (racemic);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(3-methyl-3,6- diaza-bicyclo[3.2.1]octane-6- sulfonyl)-benzylamide (racemic);
cis-Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(2-aza- bicyclo[3.1.0]hexane-2-sulfonyl)- benzylamide (racemic);
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(2,6-dioxa-9-aza- spiro[4.5]decane-9-sulfonyl)- benzylamide (racemic);
Furo[2,3-c]pyridine-2-carboxylic acid 4-(tetrahydro-pyran-3- sulfonyl)-benzylamide (racemic);
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(tetrahydro- pyran-3-sulfonyl)-benzylamide (racemic);
Furo[2,3-c]pyridine-2-carboxylic acid 4-[4-(tetrahydro-pyran-4-yl)- piperazine-1-sulfonyl]- benzylamide;
Imidazo[1,2-a]pyridine-6- carboxylic acid 4-(1-acetyl- piperidine-4-sulfonyl)- benzylamide;
cis-1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(2-oxa-5-aza- bicyclo[2.2.1]heptane-5-sulfonyl)- benzylamide (racemic);
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-[4-(2-methoxy- ethyl)-piperazine-1-sulfonyl]- benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(4- hydroxymethyl-piperidine-1- sulfonyl)-benzylamide;
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(3,3-difluoro- pyrrolidine-1-sulfonyl)- benzylamide;
cis-1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(4,4-difluoro- hexahydro-cyclopenta[c]pyrrole-2- sulfonyl)-benzylamide (racemic);
cis-1H-Pyrazolo[3,4-b]pyridine-5- carobyxlic acid 4-(5,5-difluoro- hexahydro-cyclopenta[c]pyrrole-2- sulfonyl)-benzylamide (racemic);
cis-1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(hexahydro- furo[2,3-c]pyrrole-5-sulfonyl)- benzylamide (racemic);
Imidazo[1,2-a]pyrimidine-6- carboxylic acid 4-(1-isobutyl- piperidine-4-sulfinyl)-benzylamide (racemic);
Furo[2,3-c]pyridine-2-carboxylic acid 4-(1-isobutyl-piperidine-4- sulfinyl)-benzylamide (racemic);
1H-Pyrazolo[3,4-b]pyridine-5- carboxylic acid 4-(1-isobutyl- piperidine-4-sulfinyl)-benzylamide (racemic);
1H-Pyrrolo[3,2-c]pyridine-2- carboxylic acid 4-(1-isobutyl- piperidine-4-sulfinyl)-benzylamide (racemic);
8-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-1,8-diaza- spiro[4.6]undecane-1-carboxylic acid tert-butyl ester (racemic);
3-[(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonylamino)-methyl]-1- oxa-8-aza-spiro[4.5]decane-8- carboxylic acid tert-butyl ester (racemic);
1-(4-{[(Imidazo[1,2-a]pyridine-6- carbonyl)-amino]-methyl}- benzenesulfonyl)-1,8-diaza- spiro[4.5]decane-8-carboxylic acid tert-butyl ester;
3-[1-(4-{[(Imidazo[1,2-a]pyridine- 6-carbonyl)-amino]-methyl}- benzenesulfonyl)-2,3-dihydro-1H- indol-3-yl]-piperidine-1-carboxylic acid tert-butyl ester (mixture of diastereomers);
N-(4-(1-isobutylpiperidin-4- ylsulfinyl)benzyl)H-imidazo[1,2- a]pyridine-6-carboxamide (racemic);
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl]phenyl]methyl] imidazo[1,2-a]pyrimidine-6- carboxamide;
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl]phenyl]metyl] furo[2,3-c]pyridine-2-carboxamide;
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl)phenyl]methyl]- 1H-pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl]phenyl]methyl]- 1H-pyrrolo[3,2-c]pyridine-2- carboxamide;
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl]phenyl]methyl] furo[2,3-c]pyridine-2-carboxamide (single isomer);
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl]phenyl]methyl] furo[2,3-c]pyridine-2-carboxamide (single isomer);
N-[[4-(8-oxa-2-azaspiro[3.5]nonan- 2- ylsulfonyl)phenyl]methyl]imdazo [1,2-a]pyridine-6-carboxamide;
N-[[4-(2,8-diazaspiro[3.5]nonan-2- ylsulfonyl)phenyl]methyl]imidazo [1,2-a]pyridine-6-carboxamide;
N-[[4-(4-tetrahydropyran-4- ylpiperazin-1- yl)sulfonylphenyl]methyl]-1,3- dihydropyrrolo[3,4-c]pyridine-2- carboxamide;
N-[[4-[(6-methyl-2,6- diazaspiro[3.4]octan-2- yl)sulfonyl]phenyl]methyl]furo[2,3- c]pyridine-2-carboxamide;
N-[[4-tetrahydropyran-4- ylsulfonyl)phenyl)methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[(4-tetrahydropyran-4- ylsulfonylphenyl)methyl]imi- dazo[1,2-a]pyrimidine-6- carboxamide;
N-[(4-tetrahydropyran-4- ylsulfonylphenyl)methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[(4-tetrahydropyran-4- ylsulfonylphenyl)methyl]-1H- pyrrolo[3,2-c]pyridine-2- carboxamide;
N-[(4-tetrahydropyran-4- ylsulfonylphenyl)methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-(4- piperidylsulfonyl)phenyl)meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-(4- piperidylsulfonyl)phenyl]meth- yl]thieno[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[(1-acetyl-4- piperidyl)sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[[1-(2,2,2- trifluoroethyl)-4- piperidyl]sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[[1-(2,2,2- trifluoroethyl)-4- piperidyl]sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyrimidine-6- carboxamide;
N-[[4-[[1-(2,2,2- trifluoroethyl)-4- piperidyl]sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[[1-(2,2,2- trifluoroethyl)-4- piperidyl]sulfonyl]phenyl]meth- yl]-1H-pyrrolo[3,2-c]pyridine- 2-carboxamide;
N-[[4-[[1-(2,2,2- trifluoroethyl)-4- piperidyl]sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrrolo[3,2-c]pyridine- 2-carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(2,6- diazaspiro[3.4]octan-6- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(7-methyl-2,7- diazaspiro[3.4]octan-2- yl)sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-oxo-2,7- diazaspiro[4.4]nonan-7- yl)sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(7-oxa-2- azaspiro[3.5]nonan-2- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1-oxa-7- azaspiro[4.4]nonan-7- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide
N-[[4-(6-oxa-2- azaspiro[3.4]octan-2- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(3S)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]-1H- pyrrolo[3,2-c]pyridine-2- carboxamide;
N-[[4-[(3S)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]imi- dazo[1,2-a]pyrimidine-6- carboxamide;
N-[[4-[(3S)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyrimidine-6- carboxamide;
N-[[4-[(3R)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]-1H- pyrrolo[3,2-c]pyridine-2- carboxamide;
N-[[4-[(3R)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]imi- dazo[1,2-a]pyrimidine-6- carboxamide;
N-[[4-[(3R)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-acetyl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[(1-acetyl-4- piperidyl)sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyrimidine-6- carboxamide;
N-[[4-[(3S)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-[(3S)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[(3R)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-[(3R)-tetrahydrofuran-3- yl]sulfonylphenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-(4- piperidylsulfonyl)phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
tert-butyl 2-[4-[(imidazo[1,2- a]pyridine-6- carbonylamino)methyl]phenyl] sulfonyl-2,8- diazaspiro[4.5]decane-8- carboxylate;
tert-butyl 7-[4-[(imidazo[1,2- a]pyridine-6- carbonylamino)methyl]phenyl] sulfonyl-1,7- diazaspiro[4.4]nonane-1- carboxylate;
tert-butyl 1-[4-[(imidazo[1,2- a]pyridine-6- carbonylamino)methyl]phenyl] sulfonyl-1,7- diazaspiro[4.4]nonane-7- carboxylate;
tert-butyl 2-[4-[(imidazo[1,2- a]pyridine-6- carbonylamino)methyl]phenyl] sulfonyl-2,8- diazaspiro[3.5]nonane-8- carboxylate;
N-[[4-(3,3-difluoroazetidin-1- yl)sulfonylphenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(azetidin-1- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
tert-butyl 2-[4-[(imidazo[1,2- a]pyridine-6- carbonylamino)methyl]phenyl] sulfonyl-2,7- diazaspiro[4.4]nonane-7- carboxylate;
tert-butyl 2-[4-[(imidazo[1,2- a]pyridine-6- carbonylamino)methyl]phenyl] sulfonyl-2,8- diazaspiro[4.5]decane-9- carboxylate;
tert-butyl 2-[4-[(imidazo[1,2- a]pyridine-6- carbonylamino)methyl]phenyl] sulfonyl-2,6- diazaspiro[4.5]decane-6- carboxylate;
N-[[4-[3- (dimethylcarbamoyl)azetidin- 1- yl]sulfonylphenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(3-hydroxyazetidin-1- yl)sulfonylphenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[3-(4-methylpiperazine- 1-carbonyl)azetidin-1- yl]sulfonylphenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-acetyl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrrolo[3,2-c]pyridine- 2-carboxamide;
N-[[4-[[1-(oxetan-3-yl)-4- piperidyl]sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[[1-(oxetan-3-yl)-4- piperidyl]sulfonyl]phenyl]meth- yl]-1H-pyrrolo[3,2-c]pyridine- 2-carboxamide;
N-[[4-[[1-(oxetan-3-yl)-4- piperidyl]sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[[1-(oxetan-3-yl)-4- piperidyl]sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyrimidine-6- carboxamide;
N-[[4-[[1-(oxetan-3-yl)-4- piperidyl]sulfonyl]phenyl]meth- yl]thieno[2,3-c]pyridine-2- carboxamide;
N-[[4-(2,8- diazaspiro[3.5]nonan-2- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1,7- diazaspiro[4.4]nonan-1- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1,7- diazaspiro[4.4]nonan-7- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(2,8- diazaspiro[4.5]decan-2- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1,7- diazaspiro[4.4]nonan-7- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1,7- diazaspiro[4.4]nonan-1- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(6-acetyl-2,6- diazaspiro[3.3]heptan-2- yl)sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
2-amino-N-[(4- morpholinosulfonylphenyl)meth- yl]-5,7-dihydropyrrolo[3,4- d]pyrimidine-6-carboxamide;
N-[[4-(2,7- diazaspiro[3.5]nonan-2- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(2,7- diazaspiro[4.4]nonan-2- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
+
N-[[4-(7-oxa-2- azaspiro[3.5]nonan-2- ylsulfonyl)phenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[(4-tetrahydropyran-4- ylsulfonylphenyl)methyl]-1,3- dihydropyrrolo[3,4-c]pyridine- 2-carboxamide;
N-[[4-[(1-acetyl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[(4-tetrahydropyran-3- ylsulfonylphenyl)methyl]-1H- pyrrolo[3,2-c]pyridine-2- carboxamide;
N-[(4-tetrahydropyran-3- ylsulfonylphenyl)methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[(4-tetrahydropyran-3- ylsulfonylphenyl)methyl]-1,3- dihydropyrrolo[3,4-c]pyridine- 2-carboxamide;
N-[[4-(7-oxa-2- azaspiro[3.5]nonan-2- ylsulfonyl)phenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[(6,6-difluoro-2- azaspiro[3.3]heptan-2- yl)sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(7-methyl-2,7- diazaspiro[3.5]nonan-2- yl)sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(8-methyl-5-oxa-2,8- diazaspiro[3.5]nonan-2- yl)sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(5-methyl-2,5- diazaspiro[3.4]octan-2- yl)sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(5-oxa-2- azaspiro[3.5]octan-2- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[(4-tetrahydropyran-3- ylsulfonylphenyl)methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[(4-tetrahydropyran-3- ylsulfonylphenyl)methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
2-amino-N-[(4- tetrahydropyran-4- ylsulfonyl]phenyl)methyl]-5,7- dihydropyrrolo[3,4- d]pyrimidine-6-carboxamide;
N-[[4-(4-tetrahydropyran-4- ylpiperazin-1- yl)sulfonylphenyl]methyl]-1,3- dihydropyrrolo[3,4-c]pyridine- 2-carboxamide;
N-[[4-[(1-acetyl-4- piperidyl)sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[4-(oxetan-3- yl)piperazin-1- yl]sulfonylphenyl]methyl]-1,3- dihydropyrrolo[3,4-c]pyridine- 2-carboxamide;
N-[[4-(3,3-difluoroazetidin-1- yl)sulfonylphenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[(1-oxo-2,7- diazaspiro[4.4]nonan-7- yl)sulfonyl]phenyl]methyl]- 1H-pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[(7-methyl-2,7- diazaspiro[3.4]octan-2- yl)sulfonyl]phenyl]methyl]- 1H-pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-(1-oxa-7- azaspiro[4.4]nonan-7- ylsulfonyl)phenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-(6-oxa-1- azaspiro[3.3]heptan-1- ylsulfonyl)phenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[(3S,5R)-3,5-dimethyl-4- (oxetan-3-yl)piperazin-1- yl]sulfonylphenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-[[1-(oxetan-3-yl)-4- piperidyl]sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-(4-methylpiperazin-1- yl)sulfonylphenyl]methyl]-1,3- dihydropyrrolo[3,4-c]pyridine- 2-carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(7-methyl-2,7- diazaspiro[3.4]octan-2- yl)sulfonyl]phenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-(7-oxa-2- azaspiro[3.5]nonan-2- ylsulfonyl)phenyl]methyl]-1,3- dihydropyrrolo[3,4-c]pyridine- 2-carboxamide;
N-[[4-[(4-pyrrolidin-1-yl-1- piperidyl)sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[(4- morpholinosulfonylphenyl)meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(4,4-difluoro- 1,3,3a,5,6,6a- hexahydrocyclopenta[c]pyrrol- 2- yl)sulfonyl]phenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-[(5,5-difluoro- 1,3,3a,4,6,6a- hexahydrocyclopenta[c]pyrrol- 2- yl)sulfonyl]phenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-[4-(2- methoxyethyl)piperazin-1- yl]sulfonylphenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-[[4-(hydroxymethyl)-1- piperidyl]sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-(3,3-difluoropyrrolidin- 1- yl)sulfonylphenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-(3,3-difluoroazetidin-1- yl)sulfonylphenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-(2,3,3a,4,6,6a- hexahydrofuro[2,3-c]pyrrol-5- ylsulfonyl)phenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-(1-oxa-7- azaspiro[4.4]nonan-7- ylsulfonyl)phenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-(2-oxa-5- azabicyclo[2.2.1]heptan-5- ylsulfonyl)phenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-(8-oxa-3- azabicyclo[3.2.1]octan-3- ylsulfonyl)phenyl]methyl]furo [2,3-c]pyridine-2-carboxamide;
N-[[4-[[(3R)-3-hydroxy-1- piperidyl]sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[[(3S)-3-hydroxy-1- piperidyl]sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-(1- piperidylsufonyl)phenyl]meth- yl]imidazo[1,5-a]pyridine-7- carboxamide;
N-[[4-[(1-methyl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(1-isopropyl-4- piperidyl)sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-propanoyl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(1-propanoyl-4- piperidyl)sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[[1-(2- methylpropanoyl)-4- piperidyl]sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-butanoyl-4- piperidyl)sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-isopropyl-4- piperidyl)sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-isopropyl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(4-amino-1- piperidyl)sulfonyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(4-hydroxy-1- piperidyl)sulfonyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-(1-oxa-4,9- diazaspiro[5.5]undecan-4- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(5-amino-3- azabicyclo[3.1.0]hexan-3- yl)sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1,8- diazaspiro[4.5]decan-8- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1-oxa-4,8- diazaspiro[5.5]undecan-4- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(2-amino-7- azaspiro[3.5]nonan-7- yl)sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(3,9- diazaspiro[5.5]undecan-3- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(2,9- diazaspiro[5.5]undecan-9- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1,8- diazaspiro[5.5]undecan-8- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(3,4a,5,6,7,7a- hexahydro-2H-pyrrolo[3,4- b][1,4]oxazin-5- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[[4-(aminomethyl)-3- azabicyclo[2.1.1]hexan-3- yl]sulfonyl]phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(2,3,3a,4,6,6a- hexahydro-1H-pyrrolo[3,4- c]pyrrol-5- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[3-(3-piperidyl)indolin- 1- yl]sulfonylphenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1,8- diazaspiro[4.5]decan-1- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(2,3,3a,4,6,6a- hexahydro-1H-pyrrolo[3,4- b]pyrrol-5- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(9-oxa-3,7- diazabicyclo[3.3.1]nonan-3- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1,9- diazaspiro[4.6]undecan-9- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(3,4a,5,6,7,7a- hexahydro-2H-pyrrolo[3,4- b][1,4]oxazin-4- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(1,8- diazaspiro[5.5]undecan-8- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(3,6- diazabicyclo[3.2.0]heptan-3- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(2,9- diazaspiro[5.5]undecan-2- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide;
N-[[4-(3,3a,4,5,6,6a- hexahydro-2H-pyrrolo[2,3- c]pyrrol-1- ylsulfonyl)phenyl]methyl]imi- dazo[1,2-a]pyridine-6- carboxamide
N-[[4-[(1-isopropyl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrrolo[3,2-c]pyridine- 2-carboxamide;
N-[[4-[(1-isobutyl-4- piperidyl)sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-propyl-4- piperidyl)sulfonyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-benzoyl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[[1-(benzenesulfonyl)-3- piperidyl]sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[1- (benzenesulfonyl)pyrrolidin-3- yl]sulfonyl]phenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[(1-acetyl-3- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-(1-acetylpyrrolidin-3- yl)sulfonylphenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[(1-methylsulfonyl-4- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[(1-benzoyl-3- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-(1-benzoylpyrrolidin-3- yl)sulfonylphenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[[1-(benzenesulfonyl)-4- piperidyl]sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[(1-methylsulfonyl-3- piperidyl)sulfonyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-(1- methylsulfonylpyrrolidin-3- yl)sulfonylphenyl]methyl]-1H- pyrazolo[3,4-b]pyridine-5- carboxamide;
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[[1-(2,2,2- trifluoroethyl)-4- piperidyl]sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-isopropyl-4- piperidyl)sulfinyl)phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-propyl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-isopropyl-4- piperidyl)sulfinyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-isopropyl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[[1-(2,2,2- trifluoroethyl)-4- piperidyl]sulfinyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(1-isopropyl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[[1-(2,2,2- trifluoroethyl)-4- piperidyl]sulfinyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[(R)-(1-isopropyl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-isopropyl-4- piperidyl)sulfinyl]phenyl]meth- pyl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-ethyl-4- piperidyl)sulfinyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-methyl-4- piperidyl)sulfinyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-methyl-4- piperidyl)sulfinyl)phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(1-ethyl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[(1-isobutyl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(1-propyl-4- piperidyl)sulfinyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[[1-(2,2,2- trifluoroethyl)-4- piperidyl]sulfinyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(1-propyl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide;
N-[[4-[(1-propyl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[(1-methyl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-ethyl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1H-pyrazolo[3,4- b]pyridine-5-carboxamide;
N-[[4-[(1-propyl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(S)-(1-propyl-4- piperidyl)sulfinyl]phenyl]meth- yl]furo[2,3-c]pyridine-2- carboxamide;
N-[[4-[(1-tetrahydropyran-4- yl-4- piperidyl)sulfinyl]phenyl]meth- yl]imidazo[1,2-a]pyridine-6- carboxamide;
N-[[4-[(1-ethyl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1,3-dihydropyrrolo[3,4- c]pyridine-2-carboxamide; and
N-[[4-[(1-isopropyl-4- piperidyl)sulfinyl]phenyl]meth- yl]-1H-pyrrolo[3,2-c]pyridine- 2-carboxamide;
and pharmaceutically acceptable salts thereof, stereoisomers thereof, and pharmaceutically acceptable salts of stereoisomers thereof.

### Claim 23

A pharmaceutical composition comprising:
(a) an effective amount of at least one compound of Formula I:
wherein:
E is O or is absent;
R is (a) an 8-, 9-, or 10-membered bicyclic heteroaryl comprising one heteroatom selected from N, S, and O, and one, two, or three additional N atoms, wherein said bicyclic heteroaryl is unsubstituted or is substituted with one or more substituents selected from the group consisting of deuterium, amino, alkylamino, dialkylamino, alkyl, halo, cyano, haloalkyl, hydroxy, hydroxyalkyl, and alkoxy, and wherein one or more N atoms of said bicyclic heteroaryl is optionally an N-oxide; or
(b) a five- or six-membered nitrogen-linked heterocycloalkyl ring fused to a phenyl or monocyclic six-membered heteroaryl, wherein said phenyl or heteroaryl is unsubstituted or is substituted with one or more substituents selected from the group consisting of deuterium, amino, alkylamino, dialkylamino, alkyl, halo, cyano, haloalkyl, hydroxy, hydroxyalkyl, and alkoxy;
R1 is (1) a saturated, monocyclic heterocycloalkyl, which is unsubstituted or substituted with one or more substituents RX;
wherein each RX substituent is independently selected from the group consisting of: deuterium, halo, hydroxy, cyano, —NRaRb, -alkylenyl-NRaRb, oxo, alkyl, hydroxyalkyl, cyanoalkyl, haloalkyl, alkoxy, haloalkoxy, alkoxyalkyl-, —S-alkyl, alkenyl, alkynyl, aryl, arylalkyl-, aryloxy-, arylalkoxy-, cycloalkyl, cycloalkoxy, (cycloalkyl)alkyl-, heterocycloalkyl, (heterocycloalkyl)alkyl-, (heterocycloalkyl)alkoxy-, —C(O)alkyl, —CO2alkyl, —CO2H, —C(O)cycloalkyl, —C(O)heterocycloalkyl, —S(O)-alkyl, —SO2-alkyl, —SO2-aryl, —SO2-(haloalkyl), —CONH2, C(O)NH(alkyl), —C(O)NH(haloalkyl), —C(O)N(alkyl)2, —C(O)NH(cycloalkyl), heteroaryl, (heteroaryl)alkyl-, —N(Rc)—C(O)-alkyl, —N(Rc)—C(O)-aryl, —N(Rc)—CO2-alkyl, —SO2NH2, —SO2NH(alkyl), —SO2N(alkyl)2, —SO2NH(cycloalkyl), and —N(H)(SO2alkyl), or two adjacent RX substituents taken together form a phenyl ring,
wherein each of said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, and phenyl substituents within RX is independently unsubstituted or substituted with one or more substituents selected from the group consisting of alkyl, halo, hydroxy, cyano, alkoxy, amino, —C(O)alkyl, and —CO2alkyl;
wherein Ra and Rb are each independently H, alkyl, alkoxy, alkoxyalkyl, cyanoalkyl, or haloalkyl; and
Rc is H or alkyl; or
(2) a saturated, bicyclic or tricyclic, nitrogen-linked heterocycloalkyl, wherein said heterocycloalkyl comprises a fused, bridged, or spiro bicyclic system, and said heterocycloalkyl is unsubstituted or substituted with one or more substituents independently selected from the group consisting of: alkyl, halo, haloalkyl, hydroxy, hydroxyalkyl, alkoxy, cyano, cyanoalkyl, oxo, —NRdRe, -alkylenyl-NRdRe, —C(O)alkyl, —CO2alkyl, and —SO2alkyl;
wherein Rd is H or alkyl and Re is H, alkyl, haloalkyl, —C(O)alkyl, —CO2alkyl, or —SO2alkyl; and
R2 and R3 are each independently H or deuterium;
or a pharmaceutically acceptable salt thereof,
with the proviso that the compound of Formula I is not one of the following compounds:
and (b) a pharmaceutically acceptable carrier.

### Claim 24 (depends on 23)

The pharmaceutical composition of claim 23, further comprising therapeutically effective amounts of one or more additional adjunctive active agents.

### Claim 25 (depends on 24)

The pharmaceutical composition of claim 24, wherein said one or more additional adjuctive active agents are selected from the group consisting of cytotoxic agent, cisplatin, doxorubicin, taxotere, taxol, etoposide, irinotecan, camptostar, topotecan, paclitaxel, docetaxel, the epothilones, tamoxifen, 5-fluorouracil, methoxtrexate, temozolomide, cyclophosphamide, SCH 66336, tipifarnib (Zarnestra®), R115777, L778,123, BMS 214662, Iressa®, Tarceva®, C225, GLEEVEC®, Intron®, Peg-Intron®, aromatase combinations, ara-C, adriamycin, cytoxan, gemcitabine, Uracil mustard, Chlormethine, Ifosfamide, Melphalan, Chlorambucil, Pipobroman, Triethylenemelamine, Triethylenethiophosphoramine, Busulfan, Carmustine, Lomustine, Streptozocin, Dacarbazine, Floxuridine, Cytarabine, 6-Mercaptopurine, 6-Thioguanine, Fludarabine phosphate, oxaliplatin, leucovirin, oxaliplatin (ELOXATIN®), Pentostatine, Vinblastine, Vincristine, Vindesine, Bleomycin, Dactinomycin, Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mithramycin™, Deoxycoformycin, Mitomycin-C, L-Asparaginase, Teniposide 17α-Ethinylestradiol, Diethylstilbestrol, Testosterone, Prednisone, Fluoxymesterone, Dromostanolone propionate, Testolactone, Megestrol acetate, Methylprednisolone, Methyltestosterone, Prednisolone, Triamcinolone, Chlorotrianisene, Hydroxyprogesterone, Aminoglutethimide, Estramustine, Medroxyprogesteroneacetate, Leuprolide, Flutamide, Toremifene, goserelin, Carboplatin, Hydroxyurea, Amsacrine, Procarbazine, Mitotane, Mitoxantrone, Levamisole, Navelbene, Anastrazole, Letrazole, Capecitabine, Reloxafine, Droloxafine, Hexamethylmelamine, Avastin, herceptin, Bexxar, Velcade, Zevalin, Trisenox, Xeloda, Vinorelbine, Porfimer, Erbitux, Liposomal, Thiotepa, Altretamine, Melphalan, Trastuzumab, Lerozole, Fulvestrant, Exemestane, Ifosfomide, Rituximab, C225, Campath, leucovorin, and dexamethasone, bicalutamide, carboplatin, chlorambucil, cisplatin, letrozole, megestrol, valrubicin, vinblastine, and NIASPAN®.

### Claim 26 (depends on 23)

The pharmaceutical composition of claim 23 further comprising a rescuing agent.

### Claim 27 (depends on 26)

The pharmaceutical composition of claim 26, wherein the rescuing agent is selected from the group consisting of nicotinamide, nicotinic acid, and nicotinamide mononucleotide (NMN).

### Claim 28

A method of treating a subject suffering from or diagnosed with a disease or medical condition mediated by NAMPT activity, comprising administering to the subject in need of such treatment an effective amount of at least one compound of Formula I:
wherein:
E is O or is absent;
R is (a) an 8-, 9-, or 10-membered bicyclic heteroaryl comprising one heteroatom selected from N, S, and O, and one, two, or three additional N atoms, wherein said bicyclic heteroaryl is unsubstituted or is substituted with one or more substituents selected from the group consisting of deuterium, amino, alkylamino, dialkylamino, alkyl, halo, cyano, haloalkyl, hydroxy, hydroxyalkyl, and alkoxy, and wherein one or more N atoms of said bicyclic heteroaryl is optionally an N-oxide; or
(b) a five- or six-membered nitrogen-linked heterocycloalkyl ring fused to a phenyl or monocyclic six-membered heteroaryl, wherein said phenyl or heteroaryl is unsubstituted or is substituted with one or more substituents selected from the group consisting of deuterium, amino, alkylamino, dialkylamino, alkyl, halo, cyano, haloalkyl, hydroxy, hydroxyalkyl, and alkoxy;
R1 is (1) a saturated, monocyclic heterocycloalkyl, which is unsubstituted or substituted with one or more substituents RX;
wherein each RX substituent is independently selected from the group consisting of deuterium, halo, hydroxy, cyano, —NRaRb, -alkylenyl-NRaRb, oxo, alkyl, hydroxyalkyl, cyanoalkyl, haloalkyl, alkoxy, haloalkoxy, alkoxyalkyl-, —S-alkyl, alkenyl, alkynyl, aryl, arylalkyl-, aryloxy-, arylalkoxy-, cycloalkyl, cycloalkoxy, (cycloalkyl)alkyl-, heterocycloalkyl, (heterocycloalkyl)alkyl-, (heterocycloalkyl)alkoxy-, —C(O)alkyl, —CO2alkyl, —CO2H, —C(O)cycloalkyl, —C(O)heterocycloalkyl, —S(O)-alkyl, —SO2-alkyl, —SO2-aryl, —SO2-(haloalkyl), —CONH2, C(O)NH(alkyl), —C(O)NH(haloalkyl), —C(O)N(alkyl)2, —C(O)NH(cycloalkyl), heteroaryl, (heteroaryl)alkyl-, —N(Rc)—C(O)-alkyl, —N(Rc)—C(O)-aryl, —N(Rc)—CO2-alkyl, —SO2NH2, —SO2NH(alkyl), —SO2N(alkyl)2, —SO2NH(cycloalkyl), and —N(H)(SO2alkyl), or two adjacent RX substituents taken together form a phenyl ring,
wherein each of said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, and phenyl substituents within RX is independently unsubstituted or substituted with one or more substituents selected from the group consisting of alkyl, halo, hydroxy, cyano, alkoxy, amino, —C(O)alkyl, and —CO2alkyl;
wherein Ra and Rb are each independently H, alkyl, alkoxy, alkoxyalkyl, cyanoalkyl, or haloalkyl; and
Rc is H or alkyl; or
(2) a saturated, bicyclic or tricyclic, nitrogen-linked heterocycloalkyl, wherein said heterocycloalkyl comprises a fused, bridged, or spiro bicyclic system, and said heterocycloalkyl is unsubstituted or substituted with one or more substituents independently selected from the group consisting of: alkyl, halo, haloalkyl, hydroxy, hydroxyalkyl, alkoxy, cyano, cyanoalkyl, oxo, —NRdRe, -alkylenyl-NRdRe, —C(O)alkyl, —CO2alkyl, and —SO2alkyl;
wherein Rd is H or alkyl and Re is H, alkyl, haloalkyl, —C(O)alkyl, —CO2alkyl, or —SO2alkyl; and
R2 and R3 are each independently H or deuterium;
or a pharmaceutically acceptable salt thereof,
with the proviso that the compound of Formula I is not one of the following compounds:

### Claim 29 (depends on 28)

The method of claim 28, wherein the disease or medical condition is a solid or liquid tumor, non-small cell lung cancer, leukemia, lymphoma, ovarian cancer, glioma, breast cancer, uterine cancer, colon cancer, cervical cancer, lung cancer, prostate cancer, skin cancer, rhino-gastric tumors, colorectal cancer, CNS cancer, bladder cancer, pancreatic cancer, Hodgkin's disease, rheumatoid arthritis, diabetes, atherosclerosis, sepsis, aging, inflammation.

### Claim 30 (depends on 28)

The method of claim 28, further comprising administering to the subject an effective amount of at least one compound selected from the group consisting of: a cytotoxic agent, cisplatin, doxorubicin, taxotere, taxol, etoposide, irinotecan, camptostar, topotecan, paclitaxel, docetaxel, the epothilones, tamoxifen, 5-fluorouracil, methoxtrexate, temozolomide, cyclophosphamide, SCH 66336, tipifarnib (Zarnestra®), R115777, L778,123, BMS 214662, Iressa®, Tarceva®, C225, GLEEVEC®, Intron®, Peg-Intron®, aromatase combinations, ara-C, adriamycin, cytoxan, gemcitabine, Uracil mustard, Chlormethine, Ifosfamide, Melphalan, Chlorambucil, Pipobroman, Triethylenemelamine, Triethylenethiophosphoramine, Busulfan, Carmustine, Lomustine, Streptozocin, Dacarbazine, Floxuridine, Cytarabine, 6-Mercaptopurine, 6-Thioguanine, Fludarabine phosphate, leucovirin, oxaliplatin (ELOXATIN®), Pentostatine, vincristine, Vindesine, Bleomycin, Dactinomycin, Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mithramycin™, Deoxycoformycin, Mitomycin-C, L-Asparaginase, Teniposide 17α-Ethinylestradiol, Diethylstilbestrol, Testosterone, Prednisone, Fluoxymesterone, Dromostanolone propionate, Testolactone, Megestrol acetate, Methylprednisolone, Methyltestosterone, Prednisolone, Triamcinolone, Chlorotrianisene, Hydroxyprogesterone, Aminoglutethimide, Estramustine, Medroxyprogesteroneacetate, Leuprolide, Flutamide, Toremifene, goserelin, Carboplatin, Hydroxyurea, Amsacrine, Procarbazine, Mitotane, Mitoxantrone, Levamisole, Navelbene, Anastrazole, Letrazole, Capecitabine, Reloxafine, Droloxafine, Hexamethylmelamine, Avastin, herceptin, Bexxar, Velcade, Zevalin, Trisenox, Xeloda, Vinorelbine, Porfimer, Erbitux, Liposomal, Thiotepa, Altretamine, Melphalan, Trastuzumab, Lerozole, Fulvestrant, Exemestane, Ifosfomide, Rituximab, C225, Campath, leucovorin, dexamethasone, bicalutamide, chlorambucil, letrozole, megestrol, valrubicin, vinblastine, and NIASPAN®.

### Claim 31 (depends on 28)

The method of claim 28 further comprising administering an effective amount of a rescuing agent.

### Claim 32 (depends on 31)

The pharmaceutical composition of claim 31, wherein the rescuing agent is selected from the group consisting of nicotinamide, nicotinic acid, and nicotinamide mononucleotide (NMN).
